Zannos G. Grekos

CEO at Regenocyte Therapeutic

In collaboration with major international treatment and research centers, Doctor Zannos Grekos has developed many of the protocols used for adult stem cell therapy throughout the world. Dr. Grekos also trains physicians in the evaluation and treatment of patients receiving stem cell therapy. He was recently appointed to the Science Advisory Board of the United States’ Repair Stem Cell Institute. Doctor Grekos is the Chief Science Officer for Regenocyte, the first Adult Stem Cell clinic in the United States. Doctor Grekos is using Stem Cell Therapy to treat Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Ischemic Heart Disease, Pulmonary Disease and Early Senile Dementia, Macular Degeneration and Cystic Fibrosis among other conditions. In November, 2008, Dr. Grekos presented the groundbreaking results of his clinical treatment experience to the World Congress on Regenerative Biomedical Technologies in Dubai, U.A.E., and in 2007, he was invited to Washington, DC to brief the United States Senate Health Advisory Staff on the current state of stem cell research and therapy. Doctor Zannos Grekos has been a Clinical Assistant Professor for Nova Southeastern University, a Distinguished Master of the American Academy of Cardiology, a Diplomat of the American Board of Internal Medicine and a Diplomat of the American Board of Cardiovascular Disease.

Timeline

  • CEO

    Current role